MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin

BACKGROUND: Cisplatin (DDP)-based chemotherapy is the mainstay of first-line therapy for lung cancer. However, their efficacy is often limited by the existence or development of chemoresistance. The aim of this study was to find and investigate the function of miRNAs in cisplatin (DDP)-resistant non...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weili, Wang, Wenzhe, Ding, Mingjian, Zheng, Xiaoliang, Ma, Shenglin, Wang, Xiaoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828824/
https://www.ncbi.nlm.nih.gov/pubmed/27073334
http://dx.doi.org/10.1186/s12935-016-0305-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828824/
https://www.ncbi.nlm.nih.gov/pubmed/27073334
http://dx.doi.org/10.1186/s12935-016-0305-6

Ejemplares similares